IRIS
PAOLILLO, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.418
EU - Europa 3.419
NA - Nord America 3.056
SA - Sud America 633
AF - Africa 152
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 11.698
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.907
SG - Singapore 2.379
RU - Federazione Russa 1.752
CN - Cina 974
IT - Italia 627
BR - Brasile 510
HK - Hong Kong 432
VN - Vietnam 316
DE - Germania 249
NL - Olanda 180
FI - Finlandia 176
GB - Regno Unito 91
IN - India 87
CA - Canada 83
CI - Costa d'Avorio 63
IE - Irlanda 63
UA - Ucraina 59
AR - Argentina 52
SE - Svezia 52
MX - Messico 49
KR - Corea 41
BD - Bangladesh 39
FR - Francia 37
ZA - Sudafrica 35
PL - Polonia 29
AT - Austria 19
EC - Ecuador 18
ID - Indonesia 17
JP - Giappone 17
TR - Turchia 17
ES - Italia 15
PK - Pakistan 15
RO - Romania 13
CO - Colombia 12
IQ - Iraq 12
UZ - Uzbekistan 12
BE - Belgio 9
LT - Lituania 8
PY - Paraguay 8
VE - Venezuela 8
CL - Cile 7
CZ - Repubblica Ceca 7
PE - Perù 7
DZ - Algeria 6
EG - Egitto 6
IL - Israele 6
JO - Giordania 6
KE - Kenya 6
MA - Marocco 6
NP - Nepal 6
NZ - Nuova Zelanda 6
UY - Uruguay 6
AL - Albania 5
AU - Australia 5
BG - Bulgaria 5
IR - Iran 5
PH - Filippine 5
SK - Slovacchia (Repubblica Slovacca) 5
BO - Bolivia 4
CH - Svizzera 4
ET - Etiopia 4
GE - Georgia 4
JM - Giamaica 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
EU - Europa 3
LK - Sri Lanka 3
PT - Portogallo 3
SA - Arabia Saudita 3
SN - Senegal 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
GR - Grecia 2
KG - Kirghizistan 2
LB - Libano 2
MY - Malesia 2
RS - Serbia 2
SI - Slovenia 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CG - Congo 1
CM - Camerun 1
CV - Capo Verde 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GN - Guinea 1
Totale 11.672
Salva come PNG Salva come JPEG
Città #
Singapore 1.150
Hong Kong 431
Moscow 424
Ashburn 317
Beijing 312
Chandler 261
Hefei 227
Santa Clara 162
Amsterdam 143
Ho Chi Minh City 131
Naples 126
Los Angeles 118
San Jose 112
Millbury 104
Dallas 92
Napoli 91
Boston 75
Munich 73
Princeton 68
Turku 67
Seattle 59
Hanoi 58
Des Moines 56
São Paulo 56
Redondo Beach 53
Buffalo 50
Helsinki 49
Nanjing 47
Ottawa 44
New York 41
Seoul 41
Lawrence 35
Frankfurt am Main 31
Pune 31
The Dalles 30
Wilmington 30
Brooklyn 27
Mexico City 25
Milan 25
Nuremberg 25
Orem 25
Warsaw 25
Houston 22
Atlanta 19
Stockholm 19
Johannesburg 18
Rome 18
Changsha 16
Chicago 15
Falkenstein 14
Jacksonville 14
London 14
Montreal 14
Poplar 14
Tokyo 14
Chennai 13
Krefeld 13
Nanchang 13
Tianjin 13
Boardman 12
Hebei 12
Rio de Janeiro 12
Shanghai 12
Shenyang 12
Ankara 11
Dhaka 11
Phoenix 11
Tashkent 11
Belo Horizonte 10
Guangzhou 10
Kochi 10
Manchester 10
Norwalk 10
San Francisco 10
Vienna 10
Curitiba 9
Da Nang 9
Düsseldorf 9
Fortaleza 9
Haiphong 9
Salvador 9
Toronto 9
Biên Hòa 8
Bologna 8
Denver 8
Dong Ket 8
Jiaxing 8
Quito 8
Brasília 7
Buenos Aires 7
Can Tho 7
Fort Worth 7
Giugliano In Campania 7
Goiânia 7
Hangzhou 7
Mumbai 7
Querétaro 7
Quảng Ngãi 7
Amman 6
Calvizzano 6
Totale 5.977
Salva come PNG Salva come JPEG
Nome #
Efficacy, safety, adherence and persistence of PCSK9 inhibitors in clinical practice: A single country, multicenter, observational study (AT-TARGET-IT) 224
123I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation 175
Sacubitril/valsartan reduces cardiac decompensation in heart failure with preserved ejection fraction: a meta-analysis 161
Insulin resistance is associated with impaired cardiac sympathetic innervation in patients with heart failure 146
Una insospettabile signora chiamata disfunzione diastolica 146
Statin therapy modulates thickness and inflammatory profile of human epicardial adipose tissue 140
Increased epicardial adipose tissue volume correlates with cardiac sympathetic denervation in patients with heart failure 138
Impact of diabetes mellitus on lymphocyte GRK2 protein levels in patients with heart failure 131
Sleep-disordered breathing, impaired cardiac adrenergic innervation and prognosis in heart failure 131
Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure 130
Cardiac sympathetic innervation and mortality risk scores in patients with heart failure 130
Sleep-disordered breathing and epicardial adipose tissue in patients with heart failure. 129
Impact of Gender in Primary Prevention of Coronary Heart Disease With Statin Therapy: A Meta-Analysis 123
Prognostic Value of Lymphocyte G Protein-Coupled Receptor Kinase-2 Protein Levels in Patients With Heart Failure 123
Expert Review on the Prognostic Role of Echocardiography after Acute Myocardial Infarction 123
Alterations of left ventricular deformation and cardiac sympathetic derangement in patients with systolic heart failure: a 3D speckle tracking echocardiography and cardiac ¹²³I-MIBG study 122
Hypertrophic cardiomyopathy in mitochondrial disorders: description of an uncommon clinical case 120
Myocardial perfusion scintigraphy and echocardiography for detecting coronary artery disease in hypertensive patients: a meta-analysis 119
Impact of the number of comorbidities on cardiac sympathetic derangement in patients with reduced ejection fraction heart failure 119
Diabetic Cardiomyopathy: Definition, Diagnosis, and Therapeutic Implications. 118
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set 117
Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry 117
Prognostic role of transthoracic echocardiography in patients affected by heart failure and reduced ejection fraction 116
Validation of the echocardiographic assessment of epicardial adipose tissue thickness at the Rindfleisch fold for the prediction of coronary artery disease 116
Impact of aging on cardiac sympathetic innervation measured by (123)I-mIBG imaging in patients with systolic heart failure 115
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison. 114
What about chronotropic incompetence in heart failure with mildly reduced ejection fraction? Clinical and prognostic implications from the Metabolic Exercise combined with Cardiac and Kidney Indexes score dataset 111
The role of metabolic syndrome in heart failure 110
Impact of body mass index on cardiac adrenergic derangement in heart failure patients: a 123I-mIBG imaging study 110
Strike early-strike strong lipid-lowering strategy with PCSK9i in ACS patients. Real-world evidence from AT-TARGET-IT registry 109
Renal function and cardiac adrenergic impairment in patients affected by heart failure 108
Epidemiologia e Prevenzione 107
Does moderate hyperkalemia influence survival in HF? Insights from the MECKI score data base 105
Left Ventricular Function, Epicardial Adipose Tissue, and Carotid Intima-Media Thickness in Children and Adolescents With Vertical HIV Infection 105
Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies 105
Effects of novel oral anticoagulants on left atrial and left atrial appendage thrombi: an appraisal 104
Efficacy and safety of prolonged dual antiplatelet therapy: a meta-analysis of 15 randomized trials enrolling 85 265 patients 103
Echocardiographic Epicardial Adipose Tissue Thickness for Risk Stratification of Patients With Heart Failure 103
Ruolo della scintigrafia miocardica perfusionale e dell’ecocardiografia per la diagnosi di coronaropatia in pazienti ipertesi: metanalisi 102
Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials. 102
MicroRNAs: diagnostic, prognostic and therapeutic role in heart failure—a review 101
Artificial intelligence in cardiology: a peek at the future and the role of ChatGPT in cardiology practice 101
Prognostic Value of Hormonal Abnormalities in Heart Failure Patients. 99
Subclinical hypothyroidism predicts outcome in heart failure: insights from the T.O.S.CA. registry 97
[European guidelines on cardiovascular disease prevention: what's new?] 96
Prevalenza di disturbi del sonno in pazienti affetti da cardiomiopatia dilatativa e severa riduzione della funzione ventricolare sinistra 96
Italian Society of Cardiology-Italian Society of Nephrology Consensus Document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part II: From preventive strategies to treatment of patients with cardio-renal damage 95
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry 95
Revisiting a Prognosticating Algorithm from Cardiopulmonary Exercise Testing in Chronic Heart Failure (from the MECKI Score Population) 94
Nuove prospettive nella riduzione del rischio cardiovascolare: Focus su HDL 94
Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure 94
Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry 94
Heart failure patients with improved ejection fraction: Insights from the MECKI score database 93
Serum levels of pro-B-type natriuretic peptide predict reduced left atrial function in patients with systolic heart failure 93
Circulating miR-10b-5p, miR-193a-3p, and miR-1-3p Are Deregulated in Patients with Heart Failure and Correlate with Hormonal Deficiencies 92
Heart failure and anemia: Effects on prognostic variables. 92
Crosslink between atrial fibrillation and cancer: a therapeutic conundrum 91
Nuclear Assessment of Right Ventricle 91
Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients. 90
The metabolic syndrome in heart failure: insights to specific mechanisms. 90
Novel Strategies in Diagnosing Heart Failure with Preserved Ejection Fraction: A Comprehensive Literature Review 90
Innovations in medical therapy of heart failure with reduced ejection fraction 89
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 89
Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database. 89
Exploring the Prognostic Performance of MECKI Score in Heart Failure Patients with Non-Valvular Atrial Fibrillation Treated with Edoxaban 89
Associazione tra disfunzione endoteliale ed ischemia miocardica silente in pazienti con arteriopatia periferica 88
Assessment of cardiac sympathetic activity by MIBG imaging in patients with heart failure: a clinical appraisal 88
Endothelial-dependent microvascular dysfunction in type II diabetic patients without significant coronary artery stenosis. Effects on myocardial perfusion 88
Heart rate during exercise: mechanisms, behavior, and therapeutic and prognostic implications in heart failure patients with reduced ejection fraction 88
Effects of sacubitril/valsartan on exercise capacity: a prognostic improvement that starts during uptitration 87
Corrigendum to “Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database” [Int J Cardiol. 2020 Oct 15; 317: 103–110. PMID: 32360652] (International Journal of Cardiology (2020) 317 (103–110), (S0167527320312663), (10.1016/j.ijcard.2020.04.079)) 86
Statin therapy in patients with subclinical and evident peripheral artery disease: a meta-analysis 85
Il rischio cardiovascolare nelle patologie infiammatorie sistemiche 84
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study. 84
Vitamin D deficiency and clinical outcome in patients with chronic heart failure: a review 83
Prognostic value of indeterminable anaerobic threshold in heart failure. 82
Observer reproducibility of results from a low-dose (123)I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure 81
Cardiorenal syndrome: Pathophysiology as a key to the therapeutic approach in an under-diagnosed disease 80
The Non-invasive Assessment of the Pulmonary Circulation-Right Ventricular Functional Unit 78
Cardiovascular disease and psychiatric disorders: An-up-to date review 78
Diagnostic algorithms in patients with suspected coronary artery disease. Guidelines and evidence-based behaviours. 78
Novel potassium binders to optimize RAASi therapy in heart failure: A systematic review and meta-analysis 77
Glucose Metabolism Abnormalities in Heart Failure Patients: Insights and Prognostic Relevance. 77
Cardiovascular effects of antiretroviral drugs: clinical review. 76
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation 76
Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system (RAAS) blockade in heart failure patients - Part I: From RAAS identification to clinical trials 76
Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology 76
Left ventricular hypertrophy reduction and clinical events. A meta-regression analysis of 14 studies in 12,809 hypertensive patients 75
Changes of urinary albumin excretion and cardiovascular events: a meta-regression analysis of 32 randomized trials and 80,812 patients. 74
Choosing among β-blockers in heart failure patients according to β-receptors’ location and functions in the cardiopulmonary system 74
Effect of antiretroviral therapy on carotid intima-media thickness in HIV-infected patients. 73
N-Terminal Pro-B-Type natriuretic peptide and left atrial function in patients with congestive heart failure and severely reduced ejection fraction 73
The prognostic value of normal stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a meta-analysis 73
Nuclear imaging in detection and monitoring of cardiotoxicity 73
Prognostic impact of diabetes in chronic and acute heart failure 73
Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system blockade in heart failure patients - Part II: Mechanistic effects of sacubitril/valsartan, placement in current guidelines and use in clinical practice 73
Benefits of Statins in Elderly Subjects Without Established Cardiovascular Disease 72
Impact of diabetes mellitus on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123IMIBG) scintigraphic study 71
Endothelial dysfunction in type 2 diabetic patients with normal coronary arteries A digital reactive hyperemia study. 70
Ischemic heart disease in systemic inflammatory diseases. An appraisal 69
Totale 10.000
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.180
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202195 0 0 0 0 0 0 9 12 32 13 6 23
2021/2022523 14 4 4 11 9 9 12 15 67 36 97 245
2022/2023858 103 13 28 31 107 80 26 69 123 143 106 29
2023/2024772 31 99 96 40 49 92 16 123 8 37 125 56
2024/20253.954 166 154 10 37 118 255 433 258 289 404 1.476 354
2025/20264.985 849 603 819 728 1.418 414 154 0 0 0 0 0
Totale 11.945